SARS-CoV-2 (Coronavirus), Antigen Test
SARS-CoV-2 is the seventh known coronavirus causing respiratory infection in humans, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV. Based on its genome sequence, SARS-CoV-2 is a positive-sense, single-stranded RNA coronavirus (+ssRNA) belongs to the 2B group of the betacoronavirus family, which is the same family as SARS-CoV and MERS-CoV and has 70% similarity in genetic sequence to SARS. Each SARS-CoV-2 virion is approximately 50–200 nanometers in diameter and composed of several proteins including the spike (S), envelope (E), membrane (M), and nucleocapsid (N); the N protein holds the RNA genome, and the S, E, and M proteins together create the viral envelope. Its spike protein has sufficient affinity to the angiotensin-converting enzyme 2 (ACE2) receptor to use it as a mechanism of cell entry.
SARS-CoV-2 is the causative agent of coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared the 2019–20 coronavirus outbreaks a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a pandemic on 11 March 2020. Symptoms of COVID-19 range from mild fever, cough, and shortness of breath, muscle pain, diarrhea, and sore throat to pneumonia and multi-organ failure. The disease is transmitted from human-to-human by close contact, via respiratory droplets generated by sneezing and coughing. It may also spread when one touches a contaminated surface and then their face. The incubation period appears to be 2-14 days. The laboratory testing for the COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the viral nucleic acids, rapid tests to detect viral antigens and those that detect antibodies produced in response to infection. Detection of the viral RNA by molecular method such as reverse transcriptase polymerase chain reaction (RT-PCR) is preferable and widely adopted test in COVID-19 testing, especially for early detection and infection spreading management.
Antigen detection is most commonly used as a rapid screen test to detect viral particles from collected swab specimens. Although less sensitive than RT-PCR assay, antigen test can be used as an alternative test for early detection especially in the area that RT-PCR might not be available. The rapid antigen testing can also be valuable to get rapid result in doctor’s clinics, hospitals and in mass screening in public facilities like airport, schools and colleges. It is also used as a screening test in low prevalence population, where rapid testing is needed.
- Diagnosis of acute respiratory distress syndrome and severe pneumonia caused by SARS-CoV-2 coronavirus
- Useful for epidemiological surveillance and management
Positive test result indicates COVID-19 infection.
Note: if symptoms and clinical picture persist, negative results must confirm by molecular testing.
Recommendation for testing:
- For early (onset) detection use Molecular (Swab): Alternatively, Antigen test can be used, but all negative test must be retested by Molecular
- For immunity evaluation use Antibody IgG assay only
- No value or recommendation for use of IgM or IgA
Negative (Not Detected)
Nasopharyngeal swab, Nasal and/or oropharyngeal swab.
Stability
Most of antigen tests are rapid and are performed within a short time of collection.
- Int J Antimicrob Agents. 2020 Feb 17:105924. [PMID: 32081636]
- Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917. [PMID: 31992387]
- Int J Antimicrob Agents. 2020 Feb 17:105924. [PMID: 32081636]
- J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25709. [PMID: 32056249]
- Pediatr Infect Dis J. 2005 Nov;24 (11 Suppl). [PMID: 16378050]
- Euro Surveill. 2012 Sep 27;17(39). [PMID: 23041020]
- Antivir Ther. 2007;12(4 Pt B):651-8. [PMID: 17944272]